MYLAN ApS: Financial statements 2013
CVR: 28107013
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
MYLAN ApS (CVR 28107013) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -3,087 and a net result of DKK -2,309 compared with DKK -2,212 the year before. Equity in the 2013 report amounted to DKK -178,354.
- Gross Profit
- DKK -3,087
- Profit/Loss
- DKK -2,309
- Equity
- DKK -178,354
- Total Assets
- DKK 281,346
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -3 t. | -2 t. | -178 t. | - |
| 2012 | - | -3 t. | -2 t. | -176 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
MYLAN ApS has published its annual report for 2012. Gross profit came to DKK -2,934, and the net result was DKK -2,212.
About MYLAN ApS
MYLAN ApS was a Danish company of the type Anpartsselskab based in Ballerup, founded in 2004. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERCK NM ApS and NM PHARMA ApS. In 2024, the company reported a gross profit of DKK 3,631 and a net result of DKK 3,137 compared with DKK 1,952 the year before. Equity in the 2024 report amounted to DKK 198,978.